Procaine hydrochloride oral stabilised

Drug Profile

Procaine hydrochloride oral stabilised

Alternative Names: Anticort; Procaine oral stabilsed - Samaritan Pharmaceuticals; Sp 6310; SP-01; SP-01A; SP-6310; SP001

Latest Information Update: 18 Jan 2011

Price : $50

At a glance

  • Originator Georgetown University
  • Developer Pharmaplaz; Samaritan Pharmaceuticals
  • Class Aminobenzoic acids; Antidepressants; Antivirals; Benzoic acids; Local anaesthetics; Small molecules
  • Mechanism of Action Hormone modulators; Immunosuppressants; Monoamine oxidase inhibitors; Sodium channel antagonists; Virus replication inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported HIV infections; Major depressive disorder
  • Discontinued Alzheimer's disease

Most Recent Events

  • 15 Dec 2016 Biomarkers information updated
  • 18 Jan 2011 No development reported - Phase-II/III for HIV infections in USA (PO)
  • 18 Jan 2011 No development reported - Registered for Depression in Romania (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top